• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测玻璃体脱离与糖尿病黄斑水肿相关的玻璃体牵引后玻璃体内注射纤维蛋白溶酶。

Predictability of vitreous detachment following intravitreal plasmin injection in diabetic macular edema associated with vitreomacular traction.

机构信息

Mansoura Ophthalmic Center, Mansoura University, Mansoura, Egypt.

出版信息

Curr Eye Res. 2011 Jun;36(6):534-9. doi: 10.3109/02713683.2011.569868.

DOI:10.3109/02713683.2011.569868
PMID:21591862
Abstract

PURPOSE

To assess preoperative factors associated with postoperative posterior vitreous detachment (PVD) following intravitreal autologous plasmin injection in diabetic macular edema associated with vitreomacular traction.

METHODS

Twenty-five eyes with diabetic macular edema associated with vitreomacular traction as documented with optical coherence tomography were included. Approximately 0.2 IU/0.2 ml of autologous plasmin was injected intravitreally. Condition of the posterior vitreous face (degree of detachment, thickness, reflectivity, and diameter of attached vitreous base) was evaluated preoperatively and postoperatively up to 3 months.

RESULTS

PVD was achieved in ten eyes (41.7%). There was a significant difference (P = 0.03) in mean posterior vitreous face thickness between the eyes with PVD and the eyes with failed PVD. There was a significant correlation between PVD and both posterior vitreous face thickness (P < 0.03%) and degree of posterior vitreous face reflectivity (P = 0.002).

CONCLUSION

In diabetic eyes with vitreomacular traction, the prediction of PVD after plasmin injection is governed by the condition of posterior vitreous face; mainly posterior vitreous face thickness and reflectivity. Eyes with thinner, less reflective posterior vitreous face are more likely to develop PVD.

摘要

目的

评估玻璃体切割术治疗糖尿病性黄斑水肿伴玻璃体视网膜牵引相关的术后后玻璃体脱离(PVD)的术前相关因素。

方法

共纳入 25 只伴有玻璃体视网膜牵引的糖尿病性黄斑水肿眼,这些眼通过光学相干断层扫描证实存在病变。将约 0.2IU/0.2ml 的自体纤溶酶注入玻璃体内。评估术前和术后 3 个月内的后玻璃体表面状况(脱离程度、厚度、反射率和附着玻璃体基底的直径)。

结果

10 只眼(41.7%)发生 PVD。有 PVD 的眼与未发生 PVD 的眼之间的后玻璃体表面厚度平均值存在显著差异(P=0.03)。PVD 与后玻璃体表面厚度(P<0.03%)和后玻璃体表面反射率(P=0.002)均有显著相关性。

结论

在伴有玻璃体视网膜牵引的糖尿病眼中,纤溶酶注射后 PVD 的预测取决于后玻璃体表面的状况;主要是后玻璃体表面的厚度和反射率。后玻璃体表面较薄、反射率较低的眼更容易发生 PVD。

相似文献

1
Predictability of vitreous detachment following intravitreal plasmin injection in diabetic macular edema associated with vitreomacular traction.预测玻璃体脱离与糖尿病黄斑水肿相关的玻璃体牵引后玻璃体内注射纤维蛋白溶酶。
Curr Eye Res. 2011 Jun;36(6):534-9. doi: 10.3109/02713683.2011.569868.
2
Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.玻璃体内注射曲安奈德联合黄斑激光治疗弥漫性糖尿病性黄斑水肿后的玻璃体后界膜改变
Retina. 2008 Nov-Dec;28(10):1435-42. doi: 10.1097/IAE.0b013e31817f2dae.
3
Intravitreal tissue plasminogen activator to treat refractory diabetic macular edema by induction of posterior vitreous detachment.玻璃体腔内组织型纤溶酶原激活物治疗难以消退的糖尿病黄斑水肿并发玻璃体后脱离
Retina. 2011 Nov;31(10):2065-70. doi: 10.1097/IAE.0b013e31820f49ff.
4
Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.玻璃体内注射自体纤溶酶治疗与分支视网膜静脉阻塞相关的黄斑水肿。
Am J Ophthalmol. 2010 Dec;150(6):876-82. doi: 10.1016/j.ajo.2010.06.005.
5
Intrasurgical plasmin enzyme in diabetic macular edema.糖尿病性黄斑水肿的术中纤溶酶
Am J Ophthalmol. 2004 Oct;138(4):560-6. doi: 10.1016/j.ajo.2004.05.024.
6
Enzymatic Vitreolysis for Vitreomacular Traction in Diabetic Retinopathy.酶促玻璃体溶解术治疗糖尿病性视网膜病变的玻璃体黄斑牵拉
Dev Ophthalmol. 2017;60:160-164. doi: 10.1159/000460275. Epub 2017 Apr 20.
7
[Vitrectomy for diabetic macular edema associated with hyaloid posterior traction].[玻璃体切除术治疗与玻璃体后皮质牵引相关的糖尿病性黄斑水肿]
Bull Soc Belge Ophtalmol. 2000;276:43-8.
8
Pharmacologic vitreolysis in diabetic retinopathy.糖尿病性视网膜病变的药物性玻璃体溶解术。
Curr Pharm Biotechnol. 2011 Mar 1;12(3):406-9. doi: 10.2174/138920111794480543.
9
Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema.纤溶酶辅助玻璃体切割术治疗糖尿病性黄斑水肿时所切除的内界膜的超微结构
Ophthalmology. 2004 Feb;111(2):231-7. doi: 10.1016/j.ophtha.2003.06.001.
10
Intravitreal plasmin without associated vitrectomy as a treatment for refractory diabetic macular edema.不伴玻璃体切割术的玻璃体内注射纤溶酶治疗难治性糖尿病性黄斑水肿
J Ocul Pharmacol Ther. 2009 Aug;25(4):379-84. doi: 10.1089/jop.2008.0118.

引用本文的文献

1
Is Intravitreal Injection of Recombinant Tissue Plasminogen Activator Effective for the Treatment of Refractory Diabetic Macular Edema in Patients With Posterior Vitreous Detachment?玻璃体内注射重组组织型纤溶酶原激活剂对伴有玻璃体后脱离的难治性糖尿病性黄斑水肿患者有效吗?
Cureus. 2024 Feb 16;16(2):e54297. doi: 10.7759/cureus.54297. eCollection 2024 Feb.
2
Ocriplasmin for symptomatic vitreomacular adhesion.用于有症状性玻璃体黄斑粘连的奥克纤溶酶
Cochrane Database Syst Rev. 2017 Oct 17;10(10):CD011874. doi: 10.1002/14651858.CD011874.pub2.
3
Ocriplasmin - variable efficacy?
奥克纤溶酶——疗效不一?
Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1245-6. doi: 10.1007/s00417-016-3404-0. Epub 2016 Jun 4.
4
The design and validation of an optical coherence tomography-based classification system for focal vitreomacular traction.基于光学相干断层扫描的局灶性玻璃体黄斑牵拉分类系统的设计与验证
Eye (Lond). 2016 Feb;30(2):314-24; quiz 325. doi: 10.1038/eye.2015.262. Epub 2016 Jan 15.
5
High-level expression, purification, and enzymatic characterization of truncated human plasminogen (Lys531-Asn791) in the methylotrophic yeast Pichia pastoris.截短型人纤溶酶原(Lys531 - Asn791)在甲基营养型酵母毕赤酵母中的高水平表达、纯化及酶学特性分析
BMC Biotechnol. 2015 Jun 9;15:50. doi: 10.1186/s12896-015-0179-z.
6
[Pharmacological vitreolysis].[药物性玻璃体溶解术]
Ophthalmologe. 2013 Oct;110(10):935-40. doi: 10.1007/s00347-013-2829-7.
7
Vitreomacular traction syndrome: the role of intravitreal plasmin injection is still not clear.玻璃体黄斑牵引综合征:玻璃体内注射纤溶酶的作用仍不明确。
Eye (Lond). 2013 Jun;27(6):776. doi: 10.1038/eye.2013.61. Epub 2013 Apr 12.